IL116323A0 - Tachykinin antagonists their preparation and pharmaceutical compositions containing them - Google Patents
Tachykinin antagonists their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL116323A0 IL116323A0 IL11632395A IL11632395A IL116323A0 IL 116323 A0 IL116323 A0 IL 116323A0 IL 11632395 A IL11632395 A IL 11632395A IL 11632395 A IL11632395 A IL 11632395A IL 116323 A0 IL116323 A0 IL 116323A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- tachykinin antagonists
- tachykinin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9425085.9A GB9425085D0 (en) | 1994-12-13 | 1994-12-13 | Organic compounds |
| GBGB9426016.3A GB9426016D0 (en) | 1994-12-22 | 1994-12-22 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL116323A0 true IL116323A0 (en) | 1996-03-31 |
Family
ID=26306161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11632395A IL116323A0 (en) | 1994-12-13 | 1995-12-11 | Tachykinin antagonists their preparation and pharmaceutical compositions containing them |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0797583A1 (en) |
| JP (1) | JPH10511935A (en) |
| AR (1) | AR001332A1 (en) |
| AU (1) | AU4343796A (en) |
| BR (1) | BR9509997A (en) |
| CA (1) | CA2204130A1 (en) |
| CO (1) | CO4700289A1 (en) |
| CZ (1) | CZ179097A3 (en) |
| FI (1) | FI971685A (en) |
| HU (1) | HUT77002A (en) |
| IL (1) | IL116323A0 (en) |
| NO (1) | NO972526L (en) |
| PE (1) | PE38997A1 (en) |
| PL (1) | PL320217A1 (en) |
| SK (1) | SK74697A3 (en) |
| TR (1) | TR199501568A2 (en) |
| WO (1) | WO1996018643A1 (en) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117855A (en) * | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| CA2266773A1 (en) * | 1996-10-07 | 1998-04-16 | Merck Sharp & Dohme Limited | Use of a nk-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| AU759022B2 (en) | 1999-02-18 | 2003-04-03 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
| NZ552397A (en) | 2004-07-15 | 2011-04-29 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| ATE550019T1 (en) | 2005-05-17 | 2012-04-15 | Merck Sharp & Dohme | CIS-4-Ä(4-CHLOROPHENYL)SULFONYLÜ-4-(2,5-DIFLUOROPHENYL)CYCLOHEXANEPROPANE ACID FOR THE TREATMENT OF CANCER |
| KR101589551B1 (en) | 2005-07-15 | 2016-02-02 | 알바니 몰레큘라 리써치, 인크. | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| BRPI0616463A2 (en) | 2005-09-29 | 2011-06-21 | Merck & Co Inc | compound, pharmaceutical composition, and use of a compound |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| CA2664113C (en) | 2006-09-22 | 2013-05-28 | Merck & Co., Inc. | Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| PL2109608T3 (en) | 2007-01-10 | 2011-08-31 | Msd Italia Srl | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| CA2682727C (en) | 2007-04-02 | 2016-03-22 | Banyu Pharmaceutical Co., Ltd. | Indoledione derivative |
| CA2690191C (en) | 2007-06-27 | 2015-07-28 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| KR20100126467A (en) | 2008-03-03 | 2010-12-01 | 타이거 파마테크 | Tyrosine kinase inhibitors |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| US8802696B2 (en) | 2009-05-12 | 2014-08-12 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof |
| KR20120034644A (en) | 2009-05-12 | 2012-04-12 | 알바니 몰레큘라 리써치, 인크. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
| AU2010247735B2 (en) | 2009-05-12 | 2015-07-16 | Albany Molecular Research, Inc. | Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)- 1,2,3,4-tetrahydroisoquinoline and use thereof |
| BR112012008849A2 (en) | 2009-10-14 | 2015-09-22 | Schering Corp | compound, pharmaceutical composition, and use of a compound |
| EP2584903B1 (en) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
| CN103068980B (en) | 2010-08-02 | 2017-04-05 | 瑟纳治疗公司 | Using short interfering nucleic acid（siNA）The connection albumen led of mediated rnai（Cadherin related protein matter）, β 1（CTNNB1）The suppression of gene expression |
| SI2606134T1 (en) | 2010-08-17 | 2019-08-30 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
| WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
| EP2615916B1 (en) | 2010-09-16 | 2017-01-04 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel erk inhibitors |
| DK2632472T3 (en) | 2010-10-29 | 2018-03-19 | Sirna Therapeutics Inc | RNA INTERFERENCE-MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERRING NUCLEIC ACIDS (SINA) |
| WO2012087772A1 (en) | 2010-12-21 | 2012-06-28 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
| IN2013MN02170A (en) | 2011-04-21 | 2015-06-12 | Piramal Entpr Ltd | |
| EP2770987B1 (en) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| EP3919620A1 (en) | 2012-05-02 | 2021-12-08 | Sirna Therapeutics, Inc. | Short interfering nucleic acid (sina) compositions |
| JP6280554B2 (en) | 2012-09-28 | 2018-02-14 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | Novel compounds that are ERK inhibitors |
| PL2925888T3 (en) | 2012-11-28 | 2018-03-30 | Merck Sharp & Dohme Corp. | Compositions and methods for treating cancer |
| WO2014100065A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
| WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
| US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| US10975084B2 (en) | 2016-10-12 | 2021-04-13 | Merck Sharp & Dohme Corp. | KDM5 inhibitors |
| US10947234B2 (en) | 2017-11-08 | 2021-03-16 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
| US11993602B2 (en) | 2018-08-07 | 2024-05-28 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| WO2020033284A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164372A (en) * | 1989-04-28 | 1992-11-17 | Fujisawa Pharmaceutical Company, Ltd. | Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same |
| JPH05186498A (en) * | 1991-12-27 | 1993-07-27 | Japan Tobacco Inc | Proline derivative |
-
1995
- 1995-12-11 PE PE1995286859A patent/PE38997A1/en not_active Application Discontinuation
- 1995-12-11 IL IL11632395A patent/IL116323A0/en unknown
- 1995-12-12 PL PL95320217A patent/PL320217A1/en unknown
- 1995-12-12 JP JP8518261A patent/JPH10511935A/en active Pending
- 1995-12-12 WO PCT/EP1995/004910 patent/WO1996018643A1/en not_active Application Discontinuation
- 1995-12-12 HU HU9701897A patent/HUT77002A/en unknown
- 1995-12-12 CA CA002204130A patent/CA2204130A1/en not_active Abandoned
- 1995-12-12 BR BR9509997A patent/BR9509997A/en not_active Application Discontinuation
- 1995-12-12 EP EP95942131A patent/EP0797583A1/en not_active Withdrawn
- 1995-12-12 CO CO95058767A patent/CO4700289A1/en unknown
- 1995-12-12 SK SK746-97A patent/SK74697A3/en unknown
- 1995-12-12 AU AU43437/96A patent/AU4343796A/en not_active Abandoned
- 1995-12-12 CZ CZ971790A patent/CZ179097A3/en unknown
- 1995-12-13 AR AR33458995A patent/AR001332A1/en unknown
- 1995-12-13 TR TR95/01568A patent/TR199501568A2/en unknown
-
1997
- 1997-04-18 FI FI971685A patent/FI971685A/en not_active Application Discontinuation
- 1997-06-03 NO NO972526A patent/NO972526L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK74697A3 (en) | 1997-11-05 |
| CZ179097A3 (en) | 1997-10-15 |
| FI971685A0 (en) | 1997-04-18 |
| EP0797583A1 (en) | 1997-10-01 |
| WO1996018643A1 (en) | 1996-06-20 |
| TR199501568A2 (en) | 1996-07-21 |
| CA2204130A1 (en) | 1996-06-20 |
| AR001332A1 (en) | 1997-10-22 |
| NO972526D0 (en) | 1997-06-03 |
| MX9703957A (en) | 1997-09-30 |
| CO4700289A1 (en) | 1998-12-29 |
| JPH10511935A (en) | 1998-11-17 |
| PE38997A1 (en) | 1997-10-02 |
| FI971685A (en) | 1997-08-13 |
| PL320217A1 (en) | 1997-09-15 |
| BR9509997A (en) | 1997-12-30 |
| AU4343796A (en) | 1996-07-03 |
| HUT77002A (en) | 1998-03-02 |
| NO972526L (en) | 1997-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL116323A0 (en) | Tachykinin antagonists their preparation and pharmaceutical compositions containing them | |
| IL121236A0 (en) | Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them | |
| IL119995A0 (en) | Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them | |
| IL117860A0 (en) | Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them | |
| IL116512A0 (en) | Cyclic peptides their preparation and pharmaceutical compositions containing them | |
| IL121235A0 (en) | Bicyclic-fused pyridines their preparation and pharmaceutical compositions containing them | |
| IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
| IL122293A0 (en) | Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them | |
| IL122618A0 (en) | Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them | |
| IL111518A (en) | Isoquinolines their preparation and pharmaceutical compositions containing them | |
| HUP9904363A3 (en) | Piperidine ether muscarinic antagonists and pharmaceutical compositions containing them | |
| IL125710A0 (en) | Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them | |
| IL115905A0 (en) | Sordarin derivatives their preparation and pharmaceutical compositions containing them | |
| IL115324A0 (en) | Neurokinin antagonist compounds their preparation and pharmaceutical compositions containing them | |
| IL119316A (en) | Hydroxypyridinones their preparation and pharmaceutical compositions containing them | |
| IL117554A0 (en) | Imidazoquinazolines their preparation and pharmaceutical compositions containing them | |
| IL112889A (en) | Beta-lactams their preparation and pharmaceutical compositions containing them | |
| IL117815A0 (en) | Ascomycins their preparation and pharmaceutical compositions containing them | |
| IL123322A0 (en) | Tetrahydroquinolines their preparation and pharmaceutical compositions containing them | |
| IL108073A0 (en) | Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them | |
| IL117817A0 (en) | N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them | |
| IL125998A0 (en) | Taxoids preparation thereof and pharmaceutical compositions containing them | |
| HUP0002929A3 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same | |
| IL114623A0 (en) | Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them | |
| IL119371A0 (en) | Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them |